Fatal myocardial infarction in the Scottish adjuvant tamoxifen trial. The Scottish Breast Cancer Committee (Q35180289)

7 August 2017

Fatal myocardial infarction in the Scottish adjuvant tamoxifen trial. The Scottish Breast Cancer Committee (English)

1 reference

7 August 2017

myocardial infarction

1 reference

1 reference

1 reference

McDonald CC

1

1 reference

PubMed ID

1912833

7 August 2017

Stewart HJ

series ordinal

2

1 reference

PubMed ID

1912833

7 August 2017

language of work or name

English

0 references

publication date

1 August 1991

1 reference

7 August 2017

1 reference

7 August 2017

303

1 reference

7 August 2017

6800

1 reference

7 August 2017

435-437

1 reference

The pharmacology and clinical uses of tamoxifen

7 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1670561

A New Anti-oestrogenic Agent in Late Breast Cancer: An Early Clinical Appraisal of ICI46474

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1670561

Estrogen replacement therapy and protection from acute myocardial infarction

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1670561

Adjuvant tamoxifen in primary breast cancer: influence on plasma lipids and antithrombin III levels

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1670561

Tamoxifen, serum lipoproteins and cardiovascular risk

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1670561

Effect of tamoxifen on oestrogen binding, lipid and lipoprotein concentrations and blood clotting parameters in premenopausal women with breast pain

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1670561

Tamoxifen and arterial thrombosis

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1670561

A pilot trial to evaluate the acute toxicity and feasibility of tamoxifen for prevention of breast cancer

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1670561

Effects of tamoxifen therapy on lipid and lipoprotein levels in postmenopausal patients with node-negative breast cancer.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1670561

Effect of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice

13 July 2018

1 reference

12 December 2020

Effects of tamoxifen on spinal bone density in women with breast cancer

1 reference

12 December 2020

Bone mineral density in women with breast cancer treated with adjuvant tamoxifen for at least two years

1 reference

12 December 2020

Tamoxifen inhibits osteoclast-mediated resorption of trabecular bone in ovarian hormone-deficient rats

1 reference

12 December 2020

Prolonging tamoxifen therapy for primary breast cancer. Findings from the National Surgical Adjuvant Breast and Bowel Project clinical trial

1 reference

12 December 2020

Oestrogens, arterial status, and postmenopausal women

1 reference

12 December 2020

Identifiers

DOI

10.1136/BMJ.303.6800.435

1 reference

7 August 2017

1 reference

7 August 2017

1 reference

PubMed ID

1912833